Saar Gill

Saar Gill

University of Pennsylvania - Philadelphia / United States
Others
AD Scientific Index ID: 1497508
person_outline Saar Gill's MOST POPULAR ARTICLES
1-) Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyAlternative Splicing of CD19 Enables Resistance to CART-19E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...Cancer discovery 5 (12), 1282-1295, 20159742015
2-) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphomaMP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ...Cell 142 (5), 699-713, 20109662010
3-) Human chimeric antigen receptor macrophages for cancer immunotherapyM Klichinsky, M Ruella, O Shestova, XM Lu, A Best, M Zeeman, ...Nature biotechnology 38 (8), 947-953, 20205482020
4-) Decade-long leukaemia remissions with persistence of CD4+ CAR T cellsJJ Melenhorst, GM Chen, M Wang, DL Porter, C Chen, MKA Collins, ...Nature 602 (7897), 503-509, 20226882022
5-) Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesM Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ...The Journal of clinical investigation 126 (10), 3814-3826, 20166282016